Sino Partners advises Chinese health technology, policy consultancy and public health service businesses engaging with Oceania's public health sector, and supports Oceania governments and health agencies access Chinese expertise, technology and operational experience.
China's public health infrastructure - built at unprecedented scale and pace - has generated world-leading expertise in epidemic response, digital health surveillance, community health delivery and population health management. Oceania health systems are increasingly looking to international experience and technology to address challenges in system capacity, equity and efficiency.
Sino Partners operates at the intersection of these two health systems - facilitating the responsible transfer of Chinese public health technology, expertise and innovation to Oceania contexts, and helping Chinese health businesses navigate the regulatory, policy and procurement environment of Australia and New Zealand.
Specialist advisory at the intersection of Chinese and Oceania public health systems.
Market entry advisory for Chinese digital health platforms, public health surveillance systems and population health management technology entering Australian and New Zealand government health markets.
Cross-jurisdictional advisory on Chinese public health policy models, system design approaches and operational experience for Oceania health agencies.
Advisory on Australian and New Zealand government health procurement processes, panel arrangements and tender requirements for Chinese health technology businesses.
Facilitation of formal bilateral health partnerships, memoranda of understanding and collaborative programs between Chinese and Oceania health agencies.
Advisory on the Health Technology Assessment (HTA) processes in Australia and New Zealand for Chinese health technology businesses seeking public reimbursement.
Comprehensive intelligence on Oceania's public health policy direction, digital health investment priorities and technology procurement pipeline.
Australia's Therapeutic Goods Administration (TGA) and the Australian Digital Health Agency (ADHA), alongside New Zealand's Medsafe and Digital Health Agency, create a complex but navigable regulatory environment for Chinese health technology businesses. Understanding these systems from the outset is critical to commercial success.
Sino Partners has deep knowledge of both regulatory frameworks and provides clear, actionable advisory to Chinese businesses on the fastest and most cost-effective pathways to market.
Deep understanding of Australian TGA, ADHA, and New Zealand Medsafe and Digital Health Agency frameworks for health technology and services.
Knowledge of Australian and New Zealand government health procurement processes, panel arrangements and evaluation criteria.
Understanding of China's public health system, digital health infrastructure and health technology development landscape.
Current intelligence on Oceania's public health policy priorities, digital health investment direction and system reform agenda.
Established capability in facilitating formal bilateral health engagements between Chinese and Oceania health organisations.
Public health engagement requires the highest professional standards and cultural sensitivity - both of which are central to our approach.
Contact our public health advisory team to discuss your market entry strategy or bilateral engagement objectives.
Start a Conversation →